tirzepatide cancer risk BREAKING NEWS π¨ A new study from the University of Michigan found that SHRINKS BREAST TUMORS IN MICE. For women 40β55, this matters. Weight gain and breast cancer both Tirzepatide and Cancer Risk: What
Description
The medication masked the symptoms without correcting the hormonal environment
About 12% of Americans have taken one of these popular medications for weight loss, according to a 2025 report by RAND, a nonprofit research organization
Neither Cora's nor Belle's compounded versions have been independently evaluated at this scale
However, very recently, on February 13, 2020, the US Food and Drug Administration (FDA) ordered the withdrawal of lorcaserin from markets, as a clinical trial to assess drug safety showed an increased risk of cancer
Incompatible with Wegovy
doi: 10.1089/met.2020.0049
